{"id":235875,"date":"2026-04-24T22:13:01","date_gmt":"2026-04-25T03:13:01","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/04\/phage-therapy-case-reveals-hidden-antibodies-can-block-treatment-of-drug-resistant-infections"},"modified":"2026-04-24T22:13:01","modified_gmt":"2026-04-25T03:13:01","slug":"phage-therapy-case-reveals-hidden-antibodies-can-block-treatment-of-drug-resistant-infections","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/04\/phage-therapy-case-reveals-hidden-antibodies-can-block-treatment-of-drug-resistant-infections","title":{"rendered":"Phage therapy case reveals hidden antibodies can block treatment of drug-resistant infections"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/phage-therapy-case-reveals-hidden-antibodies-can-block-treatment-of-drug-resistant-infections.jpg\"><\/a><\/p>\n<p>A new treatment for patients with life-threatening infectious diseases is being pioneered in Melbourne by researchers at The Alfred and Monash University. VICPhage, a clinical partnership between The Alfred and Monash, is one of the first in Australia to offer end-to-end capacity in phage therapy to treat some of the most challenging infections.<\/p>\n<p>It involves injecting a patient with viruses called bacteriophages, or phages for short, to kill bacterial infections that have not responded to other treatments.<\/p>\n<p>Professor Anton Peleg, Director of the Department of Infectious Diseases at The Alfred and Monash University and the Center to Impact AMR at Monash University, is co-lead of VICPhage and senior author of a <a href=\"https:\/\/doi.org\/10.1038\/s41591-026-04301-0\" target=\"_blank\">new paper published in <i>Nature Medicine<\/i><\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A new treatment for patients with life-threatening infectious diseases is being pioneered in Melbourne by researchers at The Alfred and Monash University. VICPhage, a clinical partnership between The Alfred and Monash, is one of the first in Australia to offer end-to-end capacity in phage therapy to treat some of the most challenging infections. It involves [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-235875","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/235875","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=235875"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/235875\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=235875"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=235875"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=235875"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}